Roche Diagnostics Corporation Confirm Cd79a Rabbitmono

Roche Diagnostics Corporation confirm cd79a rabbitmono; ventana medical systems, inc. (ventana) confirm anti-cd79a (sp18) rabbit monoclonal primary antibody is intended for the detection of cd79a in normal and neoplastic human tissues. anti- cd79a is directed against a protein expressed on the surface of b lymphocytes at all stages of maturation, from b lymphocyte precursors through plasma cells. expression of cd79a may aid in the identification of b cell lineage in malignant lymphomas. the antibody is intended for qualitative staining in sections of formalin fixed, paraffin embedded tissue. this product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information and proper controls. this antibody is intended for in vitro diagnostic (ivd) use. - ROCHMSD (Additional S&H or Hazmat Fees May Apply)